本报讯 （记者金婉霞）日前，记者获悉，2025上海国际生物医药产业周（下称"产业周"）将于10月13日至17日在上海张江 科学会堂举办。记者从主办方了解到，本届产业周以"链动全球赋能产业"为主题，采用"1+1+15+N"架构：包括1场开幕活动、1 场同期举办的成果展览、15场系列专题论坛、全年举办的N场系列主题活动。 本届产业周"大咖"云集，邀请到了科学界、产业界、投资界的多位"顶流"到场。比如，在科学界，2019年诺贝尔生理学或 医学奖得主、约翰斯·霍普金斯大学医学院教授格雷格·塞门扎，美国科学院院士、中国科学院外籍院士、百济神州联合创始人 王晓东，中国科学院院士、北京大学李兆基讲席教授谢晓亮，赵国屏、林国强、岳建民等多位中国科学院院士以及清华大学药 学院创始院长丁胜等将出席产业周。 此外，直观医疗董事会执行主席盖瑞·古萨特、联影集团董事长薛敏、英矽智能联合首席执行官兼首席科学官任峰、深势科 技创始人兼首席执行官孙伟杰、赛默飞中国区总裁方明杰、博睿康技术（上海）股份有限公司董事长胥红来等国内外知名企业 负责人以及北极光创投创始管理合伙人邓锋、上海国有资本投资有限公司副总裁陆雯、比邻星创投管理合伙人李喆、奥博 ...

Group 1 - The meeting between the Secretary of the Provincial Party Committee and the CEO of Danaher Corporation highlights the strategic importance of Jiangsu in China's reform and opening-up efforts [1][3] - Jiangsu is positioned as a frontier for China's opening-up, with a solid industrial foundation and vast market potential, particularly in the biopharmaceutical sector [3] - Danaher Corporation, as a Fortune 500 company, aligns well with Jiangsu's key industries, and its increased investment in the region reflects strategic foresight [3] Group 2 - The Secretary expressed hope that Danaher would continue to deepen its investment in Jiangsu, sharing development opportunities and enhancing product offerings to meet public health needs [3] - Danaher’s CEO acknowledged the favorable environment in Jiangsu that has contributed to the company's successful investments and expressed optimism about China's development prospects and Jiangsu's market potential [3] - Danaher plans to engage deeply with Jiangsu's technology companies and research institutions to develop more quality projects and foster mutually beneficial cooperation [3]

Core Insights - Cross-border trade facilitation is crucial for creating a market-oriented, rule-of-law, and international business environment, supporting high-quality development and high-level openness [1] - Wuxi has been selected as a pilot city for the cross-border trade facilitation initiative for three consecutive years, with significant improvements in foreign trade performance [1] Group 1: Trade Facilitation Initiatives - The cross-border trade facilitation special action launched in April aims to enhance regulatory services and implement various measures to benefit enterprises, resulting in Wuxi's foreign trade import and export reaching 535.34 billion yuan, a year-on-year increase of 7.2% [1] - The "China-Kyrgyzstan-Uzbekistan" international freight train has been operational, saving 30% in logistics costs and providing a stable new channel for the Belt and Road market [2] - Wuxi has expanded its logistics network through various modes, including rail, air, and water transport, enhancing regional logistics capabilities [2] Group 2: Industry Support Measures - The implementation of the "white list" system for importing hazardous chemicals has expedited customs clearance for high-tech enterprises, significantly reducing logistics and material loss costs [3] - The "white list" pilot in the biopharmaceutical sector has been expanded, allowing companies to import research materials more efficiently, thus accelerating innovation in the industry [4] Group 3: E-commerce and New Business Models - Wuxi has established a comprehensive customs supervision center for general goods, express delivery, and cross-border e-commerce, operating 24/7 to attract major e-commerce companies [5] - In the first eight months of the year, Wuxi Customs processed 11.96 million cross-border e-commerce export packages, a year-on-year increase of 118% [5] - The optimization of customs processes has enhanced the confidence of enterprises and stimulated new business vitality, creating a positive cycle of increased trade and business growth [6]

□ 本报记者 王梦然 今年8月，《中国（江苏）自由贸易试验区生物医药全产业链开放创新发展方案》获得国务院批复并正 式发布。9月16日，省政府召开新闻发布会，深度解读该方案背后的"首创性"与"集成性"，以3个关键词 勾勒出江苏生物医药产业开放创新的新蓝图：从实验室研发到临床使用全流程加速，让"好药"研发、通 关、使用环节实现"全程绿灯"；从全球高端人才到跨境数据资源自由流通，让百姓在家门口就能挂上外 籍专家号……这场覆盖全链条的改革实践，让"江苏造"创新药离市场更近，更快造福患者，折射民生温 度。 三大关键词锚定"全链创新" 该方案以"全链条改革、制度型开放、高水平创新"为核心骨架，系统构建起覆盖生物医药产业研发、生 产、流通、使用全周期的创新体系，每个关键词都精准破解产业发展痛点。 "一条链的改革，贯通6个方面18项政策集成。"省商务厅厅长司勇介绍，方案从增强研发创新能力、提 升审批服务水平、构建生产流通体系、完善采购使用政策、加大要素保障、守牢安全底线6个方面，细 化18项举措，核心目标是为国家探制度、为江苏赋动能、为企业解难题。 "全链条改革"立足优势精准破局。江苏生物医药产业规模占全国1/8，创新药获批 ...

江苏自贸区生物医药迎全产业链发展 江南时报讯（记者 钱月明） 生物医药一头连着市场，一头牵系民生；一头扎根国内创新土壤，一头链 接国际开放市场。9月16日，江苏省人民政府召开中国（江苏）自由贸易试验区生物医药全产业链开放 创新发展新闻发布会。江苏省商务厅厅长司勇表示，生物医药全产业链开放创新是一条跨越实验室与临 床距离、贯通科技成果与产业应用的创新之路，是一幅从政策高地到民生暖意的温暖画卷，更是一场以 制度创新激活全域发展动能的重要实践。 制度型开放，面向全球配资源。例如，高端人才职称比照认定，家门口就能挂上国际专家号。文件深化 生物医药国际职业资格比照认定，意味着如果外籍人才拥有国际生物分子学技师、注册临床数据管理 员、认证细胞技术专业人员等权威国际职业资格证明，到江苏自贸试验区来工作，可以直接参照相应标 准认定相应职称，不需要再逐级报考国内的职业资格。文件鼓励境外医师按规定在江苏自贸试验区内医 疗机构短期行医或从事相关服务，意味着老百姓不需要出国，到江苏自贸试验区就有机会挂到外籍专家 号，享受到境外高端医疗资源和服务等。 高水平创新，先行先试强赋能。一是聚焦最新赛道，加强核心技术攻关。聚焦当前全球生物医药 ...

9月16日，中国(江苏)自由贸易试验区生物医药全产业链开放创新发展新闻发布会举行。江苏省商务厅(自贸办)主要负责同志发布新闻，省科技厅、省工业 和信息化厅、省药监局、南京海关分管负责同志出席发布会并答记者问。 发布会现场 一粒药的改革，创下3个"第一" 文件还从3个方面探索开展先行先试，以创新赋能江苏做优做强生物医药产业链供应链。 在集成性方面，一条链的改革，贯通6方面18项政策集成。9月13日，江苏省政府正式印发《中国(江苏)自由贸易试验区生物医药全产业链开放创新发展专 项实施方案》(简称《专项实施方案》)，从增强生物医药研发创新能力、提升产品审批服务水平、构建生物医药生产流通体系、完善生物医药产品采购使 用政策、加大要素支持保障力度、守牢安全发展风险底线等6个方面提出18项落实举措，努力为国家打造具有世界影响力的战略性新兴产业集群试制度， 为江苏抢占生物医药产业制高点赋能量，为企业提升产业国际竞争力解难题。 让好药研得快、减成本、通关快、用得快 江苏生物医药形成雄厚的产业基础和圈层效应，强在产业规模，占全国1/8，居全国第一；强在创新能级，创新药获批上市数量约占全国1/3，居全国第 一；强在集群集中，一半 ...

（原标题：打通产业链卡点堵点，东莞人大建立专题台账"问诊"制造业） 南方财经记者程浩 东莞报道 日前，在东莞市加快推进现代化产业体系建设联席会上，制造业领域六个专题台账引起了参会人员的关注。这份台账深入分析当前东莞产业发展 优势，系统梳理卡点堵点问题和对策建议，条目化、清单化的问题和建议让东莞制造业"底数"一目了然。 东莞市人大常委会主任骆招群介绍，近年来，东莞精准定位产业发展方向，系统构建层次分明、梯度发展的"8+8+4"现代化产业体系。今年东莞 市人大常委会充分发挥代表作用，打造"助AI企·献良策"、重大产业项目集中视察等特色活动，紧扣人工智能赋能制造业发展、传统产业"三化"融 合发展等六个领域梳理出产业发展六份问题台账和工作台账，任务清单化推进落实，积极探索协同工作机制，助力加快建设现代化产业体系。 当前，产业体系是城市经济体系的核心组成部分，直接关联产业结构优化和转型升级，是事关一个城市兴衰成败的核心要素。 东莞从"三来一补"起步，到"五支四特"（五大支柱、四个特色），从"4+5"战略性产业集群，再到今天的"8+8+4"现代化产业体系，实现从"世界工 厂"到"科创制造强市"的跃升。近年来，东莞推动科技 ...

Core Insights - The report highlights the strong economic performance and competitiveness of towns in Hubei Province, with a focus on the top 100 towns by comprehensive competitiveness for 2025, led by Dongshi Town in Zhijiang City [1] Economic Performance - Hubei's town economies are showing steady growth, with significant increases in key economic indicators. The average general public budget revenue for the top 100 towns is 347 million yuan, up 22.9% year-on-year, and the average industrial output value is 10.853 billion yuan, up 19.2% [1] - The number of market entities is increasing, with an average of 1,653 registered enterprises, an increase of 61 from the previous year, and 45 large-scale industrial enterprises, an increase of 6 [1] - Retail sales are also on the rise, with an average social retail sales total of 2.243 billion yuan, up 21.5%, and an increase in the number of comprehensive stores or supermarkets [1] New Production Capacity - The development of new quality production capacity is driving economic upgrades in Hubei's top towns, with traditional industries undergoing technological upgrades and new industries being cultivated [2] - Traditional manufacturing is evolving towards high-end, intelligent, and green development, while resource-based industries are extending into high-value sectors [2] - The number of specialized and innovative small and medium-sized enterprises is steadily increasing, reflecting a shift towards high-tech and high-quality characteristics [2] Industrial Development - The leading industries in Hubei's top towns are becoming more robust, with a focus on 1-2 competitive industries that are being strengthened [2] - The report indicates a 58.2% increase in total fixed asset investment for the top towns, showcasing the initial effects of industrial clustering [2] Regional Integration - Many towns are deeply integrating into regional development, supporting urban agglomeration construction and providing components for key industries such as automotive and electronics [3] - Nearly 60% of Hubei's top towns are located in key urban agglomeration areas, enhancing industrial collaboration [3] Development Environment - The development environment is continuously improving, with significant enhancements in infrastructure and governance capabilities [3] - Initiatives like "Four Good Rural Roads" and digital rural construction are strengthening the foundational support for industrial growth and talent attraction [3] Strategic Importance - Hubei Province plays a crucial role in the strategic development of central China, with county economies being fundamental to this strategy, and towns serving as essential components for high-quality development [4] - The report evaluates the comprehensive competitiveness of 922 towns based on economic scale, vitality, and per capita levels, using data from 2024 [4]

Group 1 - The company plans to establish a joint venture named Shanghai Changlian Baifu Pharmaceutical Co., Ltd. with Shanghai Waigaoqiao Biopharmaceutical Industry Development Co., Ltd. [1] - The registered capital of the new company is set at 50 million yuan, with the company contributing 30 million yuan for a 60% stake, while the biopharmaceutical company will invest 20 million yuan for a 40% stake [1] - This investment is not expected to have a significant impact on the company's revenue, profit, or cash flow in the short term [1] Group 2 - The transaction is classified as a related party transaction but does not constitute a major asset reorganization [1] - The transaction has been approved by the company's independent directors, audit committee, and the board of directors, and does not require submission to the shareholders' meeting for approval [1]

Economic Performance - Jiangsu's GDP reached 6.7 trillion yuan in the first half of the year, with a year-on-year growth of 5.7%, maintaining the highest economic increment in the country [1] - The province's foreign trade import and export totaled 2.81 trillion yuan, growing by 5.2% year-on-year, with actual foreign investment at 11.54 billion USD, both ranking first in the nation [1] Reform and Support for Private Economy - Jiangsu has established a dedicated bureau for private economic development, implementing 20 policies to support private enterprises, contributing over 64% to economic growth [2] - The province's industrial output value from private enterprises increased by 8.7% year-on-year in the first half of the year [2] Investment and Financing - From January to July, private capital in the water, electricity, gas, and heat sectors increased by 36.8% on top of an 84.9% rise last year [3] - The provincial financing coordination mechanism has provided over 2 trillion yuan in loans to support nearly 10 million small and micro enterprises [3] Innovation and Financial Mechanisms - Suzhou has introduced a "four-loan linkage" mechanism, issuing loans totaling 890.61 billion yuan from October last year to August this year [4] - The digital RMB transaction volume in Suzhou exceeded 9 trillion yuan, accounting for 70% of the national total [4] Open Economy and International Cooperation - Jiangsu is enhancing its high-level openness, combining "bringing in" and "going out" strategies to create a dual open hub [5] - The province has launched over 450 institutional innovation achievements through its free trade zone, with recent approval for a comprehensive development plan for the biopharmaceutical industry [5][6] Urban-Rural Integration and Infrastructure Development - Jiangsu is advancing urban-rural integration, with 460,100 agricultural transfer populations receiving housing support through public rental and guaranteed rental housing [8] - The province is implementing a comprehensive management system for urban infrastructure, enhancing safety and intelligence in urban management [9]